Oesophageal Cancer Trial, Recruiting NCT07175155 Sponsor: Zhejiang University Condition: Oesophageal Cancer
Back to Oesophageal Cancer

Oesophageal Cancer Trial, Recruiting

NCT07175155
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are 18 years of age or older
  • People with a body mass index (BMI) of 35 or higher (a measure of body weight relative to height)
  • People who are already scheduled to have a gastroscopy or gastrointestinal endoscopy (a procedure where a thin, flexible camera is used to look inside the digestive tract)
  • People whose procedure is expected to take no longer than 45 minutes
  • People who have read and signed the trial's consent form

Who may not be able to join:

  • People who have bleeding or blood clotting problems, or any condition that would make placing a breathing aid in the mouth or throat unsafe
  • People who currently have an active infection of the mouth, nose, or throat, or who have a fever above 37.5°C
  • People who have chronic obstructive pulmonary disease (COPD) or other ongoing or sudden lung conditions that require regular or occasional oxygen use, or whose blood oxygen level is 92% or below while breathing normal air
  • People with serious problems affecting major organs, including significant heart failure, kidney failure requiring dialysis, severe liver disease, raised pressure in the skull, or an overall health status rated as severely unwell by medical classification (confirm with trial site)
  • People who are pregnant or currently breastfeeding
  • People with a known allergy to sedative medications (such as propofol) or to medical adhesive products
  • People who have sustained multiple traumatic injuries
  • People who are currently taking part in another clinical trial
  • People who have any other condition that the trial doctor considers makes participation unsuitable

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +8618616514088

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Zhejiang University
Registry
ClinicalTrials.gov
Start date
24 October 2025
Est. completion
20 August 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

The incidence of hypoxemia

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov